3 completed, 3 recruiting, 2 active not recruiting, 1 not yet recruiting. 5 Phase 1, 1 Early Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Active not recruiting 2, Recruiting 2, Completed 1 |
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Malignant Genitourinary System Neoplasm: new trials by email Literature Review of Malignant Genitourinary System Neoplasm trials Research Report on Malignant Genitourinary System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital Serious Illness Conversation Program training, ACS Geriatric Surgery Verification Program Implementation - Breast Carcinoma, Malignant Digestive System Neoplasm | Not applicable | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 4000 | 2026-11-15 | 2026-07-23 |
| Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study Non-Interventional Study - Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm | Recruiting | Wake Forest University Health Sciences | 500 | 2026-01-15 | 2026-10-07 | |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer Best Practice, Biospecimen Collection, Endoscopic Procedure - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 800 | 2021-02-21 | 2026-07-15 |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients Fecal Microbiota Transplantation, Loperamide - Colitis, Diarrhea | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 40 | 2021-02-01 | 2026-09-18 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes Patient Monitoring, Questionnaire Administration - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 | Completed | City of Hope Medical Center | 22 | 2020-08-11 | 2026-10-14 | |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 47 | 2020-07-09 | 2026-07-15 |
| Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study Biospecimen Collection, Genetic Counseling, Genetic Testing - Breast Carcinoma, Digestive System Neoplasm | Phase 1 | Completed | Mayo Clinic | 230 | 2020-06-29 | 2023-07-24 |
| Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer Biospecimen Collection, Genetic Testing, Quality-of-Life Assessment - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Early Phase 1 | Completed | Mayo Clinic | 197 | 2019-06-06 | 2024-08-14 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate - Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 152 | 2015-07-22 | 2026-10-15 |
Urogenital Neoplasms (9) · Breast Neoplasms (3) · Colitis (3) · Gastrointestinal Neoplasms (3) · Ovarian Neoplasms (3) · Brain Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Central Nervous System Neoplasms (2) · Colorectal Neoplasms (2) · Head and Neck Neoplasms (2) · Lung Neoplasms (2) · Melanoma (2) · Prostatic Neoplasms (2) · Urinary Bladder Neoplasms (2)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Male Urogenital Diseases (9) · Neoplasms by Site (9) · Urogenital Diseases (9) · Digestive System Diseases (8) · Neoplasms (8) · Gastrointestinal Diseases (7) · Colonic Diseases (5) · Intestinal Diseases (5) · Digestive System Neoplasms (4) · Endocrine System Diseases (4) · Genital Diseases (4) · Neoplasms by Histologic Type (4) · Skin Diseases (4)
CT-P13 (2) · Disulfides (2) · Fecal Microbiota Transplantation (2) · Genetic Testing (2) · Immunoglobulin G (2) · Infliximab (2) · LDP-02 (2) · Specimen Handling (2) · vedolizumab (2) · Biopsy (1) · CTLA-4 Antigen (1) · Endoscopy (1) · Genetic Counseling (1) · Ipilimumab (1) · Loperamide (1)
M.D. Anderson Cancer Center (3) · Mayo Clinic (2) · City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · Wake Forest University Health Sciences (1)
United States (9) · Puerto Rico (1)
Yinghong Wang (3) · Andrea B Apolo (1) · Glenn Lesser, MD (1) · Jewel Samadder, M.D. (1) · Laleh Melstrom (1) · Niloy J Samadder (1) · Samilia Obeng-Gyasi, MD, MPH (1)
PMID 32915679, PMID 35031545, PMID 38954785, PMID 42735684
P30CA033572 (1), UM1CA186712 (1), UM1CA186716 (1), UM1CA186717 (1), ZIABC011078 (1)